nodes	percent_of_prediction	percent_of_DWPC	metapath
Flumazenil—Mood swings—Epirubicin—prostate cancer	0.000647	0.00072	CcSEcCtD
Flumazenil—Paraesthesia—Mitoxantrone—prostate cancer	0.000647	0.00072	CcSEcCtD
Flumazenil—Dizziness—Goserelin—prostate cancer	0.000645	0.000718	CcSEcCtD
Flumazenil—Ataxia—Epirubicin—prostate cancer	0.000642	0.000715	CcSEcCtD
Flumazenil—Dyspnoea—Mitoxantrone—prostate cancer	0.000642	0.000715	CcSEcCtD
Flumazenil—Cough—Etoposide—prostate cancer	0.00064	0.000713	CcSEcCtD
Flumazenil—Somnolence—Mitoxantrone—prostate cancer	0.00064	0.000713	CcSEcCtD
Flumazenil—Dizziness—Conjugated Estrogens—prostate cancer	0.000638	0.000711	CcSEcCtD
Flumazenil—Feeling abnormal—Estradiol—prostate cancer	0.000637	0.000709	CcSEcCtD
Flumazenil—Hypertension—Etoposide—prostate cancer	0.000634	0.000705	CcSEcCtD
Flumazenil—Tinnitus—Capecitabine—prostate cancer	0.000632	0.000704	CcSEcCtD
Flumazenil—Diplopia—Doxorubicin—prostate cancer	0.000632	0.000704	CcSEcCtD
Flumazenil—Flushing—Capecitabine—prostate cancer	0.000629	0.000701	CcSEcCtD
Flumazenil—Chills—Docetaxel—prostate cancer	0.000629	0.0007	CcSEcCtD
Flumazenil—Arrhythmia—Docetaxel—prostate cancer	0.000626	0.000697	CcSEcCtD
Flumazenil—Chest pain—Etoposide—prostate cancer	0.000625	0.000695	CcSEcCtD
Flumazenil—Affect lability—Doxorubicin—prostate cancer	0.000622	0.000692	CcSEcCtD
Flumazenil—Fatigue—Mitoxantrone—prostate cancer	0.000621	0.000691	CcSEcCtD
Flumazenil—Vomiting—Goserelin—prostate cancer	0.00062	0.00069	CcSEcCtD
Flumazenil—Discomfort—Etoposide—prostate cancer	0.000617	0.000687	CcSEcCtD
Flumazenil—Pain—Mitoxantrone—prostate cancer	0.000616	0.000685	CcSEcCtD
Flumazenil—Bradycardia—Prednisone—prostate cancer	0.000615	0.000685	CcSEcCtD
Flumazenil—Rash—Goserelin—prostate cancer	0.000615	0.000684	CcSEcCtD
Flumazenil—Dermatitis—Goserelin—prostate cancer	0.000614	0.000683	CcSEcCtD
Flumazenil—Vomiting—Conjugated Estrogens—prostate cancer	0.000614	0.000683	CcSEcCtD
Flumazenil—Urticaria—Estradiol—prostate cancer	0.000614	0.000683	CcSEcCtD
Flumazenil—Headache—Goserelin—prostate cancer	0.000611	0.00068	CcSEcCtD
Flumazenil—Erythema—Docetaxel—prostate cancer	0.00061	0.000679	CcSEcCtD
Flumazenil—Rash—Conjugated Estrogens—prostate cancer	0.000609	0.000678	CcSEcCtD
Flumazenil—Chills—Capecitabine—prostate cancer	0.000609	0.000677	CcSEcCtD
Flumazenil—Dermatitis—Conjugated Estrogens—prostate cancer	0.000608	0.000677	CcSEcCtD
Flumazenil—Arrhythmia—Capecitabine—prostate cancer	0.000606	0.000674	CcSEcCtD
Flumazenil—Headache—Conjugated Estrogens—prostate cancer	0.000605	0.000673	CcSEcCtD
Flumazenil—Confusional state—Etoposide—prostate cancer	0.000604	0.000672	CcSEcCtD
Flumazenil—Hallucination—Prednisone—prostate cancer	0.000601	0.000669	CcSEcCtD
Flumazenil—Mood swings—Doxorubicin—prostate cancer	0.000599	0.000666	CcSEcCtD
Flumazenil—Ataxia—Doxorubicin—prostate cancer	0.000594	0.000662	CcSEcCtD
Flumazenil—Feeling abnormal—Mitoxantrone—prostate cancer	0.000593	0.00066	CcSEcCtD
Flumazenil—Erythema—Capecitabine—prostate cancer	0.00059	0.000657	CcSEcCtD
Flumazenil—Tachycardia—Etoposide—prostate cancer	0.000585	0.000651	CcSEcCtD
Flumazenil—Nausea—Goserelin—prostate cancer	0.000579	0.000644	CcSEcCtD
Flumazenil—Hyperhidrosis—Etoposide—prostate cancer	0.000579	0.000644	CcSEcCtD
Flumazenil—Nausea—Conjugated Estrogens—prostate cancer	0.000574	0.000638	CcSEcCtD
Flumazenil—Urticaria—Mitoxantrone—prostate cancer	0.000572	0.000637	CcSEcCtD
Flumazenil—Hypersensitivity—Estradiol—prostate cancer	0.000569	0.000634	CcSEcCtD
Flumazenil—Flushing—Prednisone—prostate cancer	0.000561	0.000624	CcSEcCtD
Flumazenil—Hypotension—Etoposide—prostate cancer	0.00056	0.000623	CcSEcCtD
Flumazenil—Vision blurred—Capecitabine—prostate cancer	0.000556	0.000619	CcSEcCtD
Flumazenil—Asthenia—Estradiol—prostate cancer	0.000554	0.000617	CcSEcCtD
Flumazenil—Tremor—Capecitabine—prostate cancer	0.000553	0.000616	CcSEcCtD
Flumazenil—Ill-defined disorder—Capecitabine—prostate cancer	0.000548	0.00061	CcSEcCtD
Flumazenil—Pruritus—Estradiol—prostate cancer	0.000547	0.000609	CcSEcCtD
Flumazenil—Arrhythmia—Prednisone—prostate cancer	0.00054	0.000601	CcSEcCtD
Flumazenil—Palpitations—Docetaxel—prostate cancer	0.000539	0.0006	CcSEcCtD
Flumazenil—Paraesthesia—Etoposide—prostate cancer	0.000538	0.000599	CcSEcCtD
Flumazenil—Dyspnoea—Etoposide—prostate cancer	0.000534	0.000594	CcSEcCtD
Flumazenil—Malaise—Capecitabine—prostate cancer	0.000532	0.000593	CcSEcCtD
Flumazenil—Somnolence—Etoposide—prostate cancer	0.000532	0.000593	CcSEcCtD
Flumazenil—Cough—Docetaxel—prostate cancer	0.000532	0.000592	CcSEcCtD
Flumazenil—Vertigo—Capecitabine—prostate cancer	0.00053	0.000591	CcSEcCtD
Flumazenil—Hypersensitivity—Mitoxantrone—prostate cancer	0.00053	0.00059	CcSEcCtD
Flumazenil—Hypertension—Docetaxel—prostate cancer	0.000527	0.000586	CcSEcCtD
Flumazenil—Drowsiness—Epirubicin—prostate cancer	0.000526	0.000586	CcSEcCtD
Flumazenil—Erythema—Prednisone—prostate cancer	0.000526	0.000585	CcSEcCtD
Flumazenil—Palpitations—Capecitabine—prostate cancer	0.000522	0.000581	CcSEcCtD
Flumazenil—Chest pain—Docetaxel—prostate cancer	0.000519	0.000578	CcSEcCtD
Flumazenil—Asthenia—Mitoxantrone—prostate cancer	0.000517	0.000575	CcSEcCtD
Flumazenil—Fatigue—Etoposide—prostate cancer	0.000516	0.000575	CcSEcCtD
Flumazenil—Cough—Capecitabine—prostate cancer	0.000515	0.000574	CcSEcCtD
Flumazenil—Pain—Etoposide—prostate cancer	0.000512	0.00057	CcSEcCtD
Flumazenil—Dizziness—Estradiol—prostate cancer	0.000511	0.000569	CcSEcCtD
Flumazenil—Hypertension—Capecitabine—prostate cancer	0.00051	0.000567	CcSEcCtD
Flumazenil—Dry mouth—Docetaxel—prostate cancer	0.000508	0.000565	CcSEcCtD
Flumazenil—Sweating—Epirubicin—prostate cancer	0.000505	0.000562	CcSEcCtD
Flumazenil—Chest pain—Capecitabine—prostate cancer	0.000503	0.00056	CcSEcCtD
Flumazenil—Confusional state—Docetaxel—prostate cancer	0.000502	0.000559	CcSEcCtD
Flumazenil—Anxiety—Capecitabine—prostate cancer	0.000501	0.000558	CcSEcCtD
Flumazenil—Discomfort—Capecitabine—prostate cancer	0.000497	0.000553	CcSEcCtD
Flumazenil—Vision blurred—Prednisone—prostate cancer	0.000496	0.000552	CcSEcCtD
Flumazenil—Feeling abnormal—Etoposide—prostate cancer	0.000494	0.000549	CcSEcCtD
Flumazenil—Dry mouth—Capecitabine—prostate cancer	0.000492	0.000547	CcSEcCtD
Flumazenil—Vomiting—Estradiol—prostate cancer	0.000491	0.000547	CcSEcCtD
Flumazenil—Ill-defined disorder—Prednisone—prostate cancer	0.000488	0.000543	CcSEcCtD
Flumazenil—Rash—Estradiol—prostate cancer	0.000487	0.000542	CcSEcCtD
Flumazenil—Drowsiness—Doxorubicin—prostate cancer	0.000487	0.000542	CcSEcCtD
Flumazenil—Dermatitis—Estradiol—prostate cancer	0.000487	0.000542	CcSEcCtD
Flumazenil—Confusional state—Capecitabine—prostate cancer	0.000486	0.000541	CcSEcCtD
Flumazenil—Tachycardia—Docetaxel—prostate cancer	0.000486	0.000541	CcSEcCtD
Flumazenil—Headache—Estradiol—prostate cancer	0.000484	0.000539	CcSEcCtD
Flumazenil—Agitation—Prednisone—prostate cancer	0.000483	0.000538	CcSEcCtD
Flumazenil—Bradycardia—Epirubicin—prostate cancer	0.000481	0.000535	CcSEcCtD
Flumazenil—Urticaria—Etoposide—prostate cancer	0.000476	0.00053	CcSEcCtD
Flumazenil—Malaise—Prednisone—prostate cancer	0.000474	0.000528	CcSEcCtD
Flumazenil—Vertigo—Prednisone—prostate cancer	0.000473	0.000526	CcSEcCtD
Flumazenil—Tachycardia—Capecitabine—prostate cancer	0.00047	0.000524	CcSEcCtD
Flumazenil—Hypoaesthesia—Epirubicin—prostate cancer	0.00047	0.000523	CcSEcCtD
Flumazenil—Sweating—Doxorubicin—prostate cancer	0.000467	0.00052	CcSEcCtD
Flumazenil—Hyperhidrosis—Capecitabine—prostate cancer	0.000466	0.000519	CcSEcCtD
Flumazenil—Hypotension—Docetaxel—prostate cancer	0.000465	0.000518	CcSEcCtD
Flumazenil—Nausea—Estradiol—prostate cancer	0.000459	0.000511	CcSEcCtD
Flumazenil—Vomiting—Mitoxantrone—prostate cancer	0.000458	0.00051	CcSEcCtD
Flumazenil—Visual impairment—Epirubicin—prostate cancer	0.000455	0.000507	CcSEcCtD
Flumazenil—Hypertension—Prednisone—prostate cancer	0.000454	0.000505	CcSEcCtD
Flumazenil—Rash—Mitoxantrone—prostate cancer	0.000454	0.000505	CcSEcCtD
Flumazenil—Dermatitis—Mitoxantrone—prostate cancer	0.000454	0.000505	CcSEcCtD
Flumazenil—Headache—Mitoxantrone—prostate cancer	0.000451	0.000502	CcSEcCtD
Flumazenil—Hypotension—Capecitabine—prostate cancer	0.00045	0.000501	CcSEcCtD
Flumazenil—Insomnia—Docetaxel—prostate cancer	0.00045	0.000501	CcSEcCtD
Flumazenil—Paraesthesia—Docetaxel—prostate cancer	0.000447	0.000497	CcSEcCtD
Flumazenil—Anxiety—Prednisone—prostate cancer	0.000446	0.000497	CcSEcCtD
Flumazenil—Bradycardia—Doxorubicin—prostate cancer	0.000445	0.000495	CcSEcCtD
Flumazenil—Dyspnoea—Docetaxel—prostate cancer	0.000444	0.000494	CcSEcCtD
Flumazenil—Somnolence—Docetaxel—prostate cancer	0.000442	0.000493	CcSEcCtD
Flumazenil—Discomfort—Prednisone—prostate cancer	0.000442	0.000492	CcSEcCtD
Flumazenil—Hypersensitivity—Etoposide—prostate cancer	0.000441	0.000491	CcSEcCtD
Flumazenil—Tinnitus—Epirubicin—prostate cancer	0.000441	0.00049	CcSEcCtD
Flumazenil—Flushing—Epirubicin—prostate cancer	0.000439	0.000488	CcSEcCtD
Flumazenil—Insomnia—Capecitabine—prostate cancer	0.000436	0.000485	CcSEcCtD
Flumazenil—Hypoaesthesia—Doxorubicin—prostate cancer	0.000435	0.000484	CcSEcCtD
Flumazenil—Paraesthesia—Capecitabine—prostate cancer	0.000433	0.000482	CcSEcCtD
Flumazenil—Asthenia—Etoposide—prostate cancer	0.00043	0.000478	CcSEcCtD
Flumazenil—Dyspnoea—Capecitabine—prostate cancer	0.00043	0.000478	CcSEcCtD
Flumazenil—Fatigue—Docetaxel—prostate cancer	0.000429	0.000478	CcSEcCtD
Flumazenil—Nausea—Mitoxantrone—prostate cancer	0.000428	0.000476	CcSEcCtD
Flumazenil—Pain—Docetaxel—prostate cancer	0.000426	0.000474	CcSEcCtD
Flumazenil—Chills—Epirubicin—prostate cancer	0.000424	0.000472	CcSEcCtD
Flumazenil—Pruritus—Etoposide—prostate cancer	0.000424	0.000472	CcSEcCtD
Flumazenil—Arrhythmia—Epirubicin—prostate cancer	0.000422	0.00047	CcSEcCtD
Flumazenil—Visual impairment—Doxorubicin—prostate cancer	0.000421	0.000469	CcSEcCtD
Flumazenil—Tachycardia—Prednisone—prostate cancer	0.000419	0.000466	CcSEcCtD
Flumazenil—Fatigue—Capecitabine—prostate cancer	0.000415	0.000462	CcSEcCtD
Flumazenil—Hyperhidrosis—Prednisone—prostate cancer	0.000415	0.000462	CcSEcCtD
Flumazenil—Pain—Capecitabine—prostate cancer	0.000412	0.000459	CcSEcCtD
Flumazenil—Erythema—Epirubicin—prostate cancer	0.000411	0.000458	CcSEcCtD
Flumazenil—Feeling abnormal—Docetaxel—prostate cancer	0.00041	0.000457	CcSEcCtD
Flumazenil—Tinnitus—Doxorubicin—prostate cancer	0.000408	0.000454	CcSEcCtD
Flumazenil—Flushing—Doxorubicin—prostate cancer	0.000406	0.000452	CcSEcCtD
Flumazenil—Tension—Epirubicin—prostate cancer	0.000404	0.000449	CcSEcCtD
Flumazenil—Nervousness—Epirubicin—prostate cancer	0.0004	0.000445	CcSEcCtD
Flumazenil—Feeling abnormal—Capecitabine—prostate cancer	0.000397	0.000442	CcSEcCtD
Flumazenil—Dizziness—Etoposide—prostate cancer	0.000396	0.000441	CcSEcCtD
Flumazenil—Chills—Doxorubicin—prostate cancer	0.000392	0.000437	CcSEcCtD
Flumazenil—Arrhythmia—Doxorubicin—prostate cancer	0.000391	0.000435	CcSEcCtD
Flumazenil—Insomnia—Prednisone—prostate cancer	0.000388	0.000432	CcSEcCtD
Flumazenil—Vision blurred—Epirubicin—prostate cancer	0.000388	0.000432	CcSEcCtD
Flumazenil—Paraesthesia—Prednisone—prostate cancer	0.000385	0.000429	CcSEcCtD
Flumazenil—Urticaria—Capecitabine—prostate cancer	0.000383	0.000426	CcSEcCtD
Flumazenil—Ill-defined disorder—Epirubicin—prostate cancer	0.000382	0.000425	CcSEcCtD
Flumazenil—Vomiting—Etoposide—prostate cancer	0.000381	0.000424	CcSEcCtD
Flumazenil—Erythema—Doxorubicin—prostate cancer	0.000381	0.000424	CcSEcCtD
Flumazenil—Agitation—Epirubicin—prostate cancer	0.000378	0.000421	CcSEcCtD
Flumazenil—Rash—Etoposide—prostate cancer	0.000378	0.00042	CcSEcCtD
Flumazenil—Dermatitis—Etoposide—prostate cancer	0.000377	0.00042	CcSEcCtD
Flumazenil—Headache—Etoposide—prostate cancer	0.000375	0.000418	CcSEcCtD
Flumazenil—Tension—Doxorubicin—prostate cancer	0.000373	0.000416	CcSEcCtD
Flumazenil—Malaise—Epirubicin—prostate cancer	0.000371	0.000413	CcSEcCtD
Flumazenil—Fatigue—Prednisone—prostate cancer	0.00037	0.000412	CcSEcCtD
Flumazenil—Nervousness—Doxorubicin—prostate cancer	0.00037	0.000411	CcSEcCtD
Flumazenil—Vertigo—Epirubicin—prostate cancer	0.00037	0.000411	CcSEcCtD
Flumazenil—Hypersensitivity—Docetaxel—prostate cancer	0.000367	0.000408	CcSEcCtD
Flumazenil—Palpitations—Epirubicin—prostate cancer	0.000364	0.000405	CcSEcCtD
Flumazenil—Cough—Epirubicin—prostate cancer	0.000359	0.0004	CcSEcCtD
Flumazenil—Vision blurred—Doxorubicin—prostate cancer	0.000359	0.000399	CcSEcCtD
Flumazenil—Asthenia—Docetaxel—prostate cancer	0.000357	0.000398	CcSEcCtD
Flumazenil—Nausea—Etoposide—prostate cancer	0.000356	0.000396	CcSEcCtD
Flumazenil—Hypertension—Epirubicin—prostate cancer	0.000355	0.000395	CcSEcCtD
Flumazenil—Hypersensitivity—Capecitabine—prostate cancer	0.000355	0.000395	CcSEcCtD
Flumazenil—Feeling abnormal—Prednisone—prostate cancer	0.000354	0.000394	CcSEcCtD
Flumazenil—Ill-defined disorder—Doxorubicin—prostate cancer	0.000353	0.000393	CcSEcCtD
Flumazenil—Pruritus—Docetaxel—prostate cancer	0.000352	0.000392	CcSEcCtD
Flumazenil—Chest pain—Epirubicin—prostate cancer	0.00035	0.00039	CcSEcCtD
Flumazenil—Agitation—Doxorubicin—prostate cancer	0.00035	0.000389	CcSEcCtD
Flumazenil—Anxiety—Epirubicin—prostate cancer	0.000349	0.000388	CcSEcCtD
Flumazenil—Discomfort—Epirubicin—prostate cancer	0.000346	0.000385	CcSEcCtD
Flumazenil—Asthenia—Capecitabine—prostate cancer	0.000346	0.000385	CcSEcCtD
Flumazenil—Malaise—Doxorubicin—prostate cancer	0.000343	0.000382	CcSEcCtD
Flumazenil—Dry mouth—Epirubicin—prostate cancer	0.000342	0.000381	CcSEcCtD
Flumazenil—Vertigo—Doxorubicin—prostate cancer	0.000342	0.000381	CcSEcCtD
Flumazenil—Urticaria—Prednisone—prostate cancer	0.000341	0.00038	CcSEcCtD
Flumazenil—Pruritus—Capecitabine—prostate cancer	0.000341	0.00038	CcSEcCtD
Flumazenil—Confusional state—Epirubicin—prostate cancer	0.000339	0.000377	CcSEcCtD
Flumazenil—Palpitations—Doxorubicin—prostate cancer	0.000336	0.000374	CcSEcCtD
Flumazenil—Cough—Doxorubicin—prostate cancer	0.000332	0.00037	CcSEcCtD
Flumazenil—Dizziness—Docetaxel—prostate cancer	0.000329	0.000366	CcSEcCtD
Flumazenil—Hypertension—Doxorubicin—prostate cancer	0.000329	0.000366	CcSEcCtD
Flumazenil—Tachycardia—Epirubicin—prostate cancer	0.000328	0.000365	CcSEcCtD
Flumazenil—Hyperhidrosis—Epirubicin—prostate cancer	0.000325	0.000361	CcSEcCtD
Flumazenil—Chest pain—Doxorubicin—prostate cancer	0.000324	0.000361	CcSEcCtD
Flumazenil—Anxiety—Doxorubicin—prostate cancer	0.000323	0.000359	CcSEcCtD
Flumazenil—Discomfort—Doxorubicin—prostate cancer	0.00032	0.000356	CcSEcCtD
Flumazenil—Dizziness—Capecitabine—prostate cancer	0.000319	0.000355	CcSEcCtD
Flumazenil—Dry mouth—Doxorubicin—prostate cancer	0.000317	0.000353	CcSEcCtD
Flumazenil—Vomiting—Docetaxel—prostate cancer	0.000316	0.000352	CcSEcCtD
Flumazenil—Hypersensitivity—Prednisone—prostate cancer	0.000316	0.000352	CcSEcCtD
Flumazenil—Rash—Docetaxel—prostate cancer	0.000314	0.000349	CcSEcCtD
Flumazenil—Hypotension—Epirubicin—prostate cancer	0.000314	0.000349	CcSEcCtD
Flumazenil—Dermatitis—Docetaxel—prostate cancer	0.000314	0.000349	CcSEcCtD
Flumazenil—Confusional state—Doxorubicin—prostate cancer	0.000313	0.000349	CcSEcCtD
Flumazenil—Headache—Docetaxel—prostate cancer	0.000312	0.000347	CcSEcCtD
Flumazenil—Asthenia—Prednisone—prostate cancer	0.000308	0.000343	CcSEcCtD
Flumazenil—Vomiting—Capecitabine—prostate cancer	0.000306	0.000341	CcSEcCtD
Flumazenil—Rash—Capecitabine—prostate cancer	0.000304	0.000338	CcSEcCtD
Flumazenil—Pruritus—Prednisone—prostate cancer	0.000304	0.000338	CcSEcCtD
Flumazenil—Insomnia—Epirubicin—prostate cancer	0.000304	0.000338	CcSEcCtD
Flumazenil—Dermatitis—Capecitabine—prostate cancer	0.000304	0.000338	CcSEcCtD
Flumazenil—Tachycardia—Doxorubicin—prostate cancer	0.000303	0.000337	CcSEcCtD
Flumazenil—Headache—Capecitabine—prostate cancer	0.000302	0.000336	CcSEcCtD
Flumazenil—Paraesthesia—Epirubicin—prostate cancer	0.000301	0.000336	CcSEcCtD
Flumazenil—Hyperhidrosis—Doxorubicin—prostate cancer	0.0003	0.000334	CcSEcCtD
Flumazenil—Dyspnoea—Epirubicin—prostate cancer	0.000299	0.000333	CcSEcCtD
Flumazenil—Somnolence—Epirubicin—prostate cancer	0.000298	0.000332	CcSEcCtD
Flumazenil—Nausea—Docetaxel—prostate cancer	0.000296	0.000329	CcSEcCtD
Flumazenil—Hypotension—Doxorubicin—prostate cancer	0.00029	0.000323	CcSEcCtD
Flumazenil—Fatigue—Epirubicin—prostate cancer	0.000289	0.000322	CcSEcCtD
Flumazenil—Pain—Epirubicin—prostate cancer	0.000287	0.00032	CcSEcCtD
Flumazenil—Nausea—Capecitabine—prostate cancer	0.000286	0.000319	CcSEcCtD
Flumazenil—Dizziness—Prednisone—prostate cancer	0.000284	0.000316	CcSEcCtD
Flumazenil—Insomnia—Doxorubicin—prostate cancer	0.000281	0.000313	CcSEcCtD
Flumazenil—Paraesthesia—Doxorubicin—prostate cancer	0.000279	0.00031	CcSEcCtD
Flumazenil—Dyspnoea—Doxorubicin—prostate cancer	0.000277	0.000308	CcSEcCtD
Flumazenil—Feeling abnormal—Epirubicin—prostate cancer	0.000277	0.000308	CcSEcCtD
Flumazenil—Somnolence—Doxorubicin—prostate cancer	0.000276	0.000307	CcSEcCtD
Flumazenil—Vomiting—Prednisone—prostate cancer	0.000273	0.000304	CcSEcCtD
Flumazenil—Rash—Prednisone—prostate cancer	0.000271	0.000301	CcSEcCtD
Flumazenil—Dermatitis—Prednisone—prostate cancer	0.00027	0.000301	CcSEcCtD
Flumazenil—Headache—Prednisone—prostate cancer	0.000269	0.000299	CcSEcCtD
Flumazenil—Fatigue—Doxorubicin—prostate cancer	0.000268	0.000298	CcSEcCtD
Flumazenil—Urticaria—Epirubicin—prostate cancer	0.000267	0.000297	CcSEcCtD
Flumazenil—Pain—Doxorubicin—prostate cancer	0.000266	0.000296	CcSEcCtD
Flumazenil—GABRA4—Neuronal System—GNG5—prostate cancer	0.000256	0.00252	CbGpPWpGaD
Flumazenil—Feeling abnormal—Doxorubicin—prostate cancer	0.000256	0.000285	CcSEcCtD
Flumazenil—GABRA2—Transmission across Chemical Synapses—ACHE—prostate cancer	0.000256	0.00252	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000255	0.00251	CbGpPWpGaD
Flumazenil—Nausea—Prednisone—prostate cancer	0.000255	0.000284	CcSEcCtD
Flumazenil—GABRB3—BDNF signaling pathway—EGR1—prostate cancer	0.000255	0.00251	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—PRKACB—prostate cancer	0.000254	0.0025	CbGpPWpGaD
Flumazenil—GABRB3—Transmission across Chemical Synapses—ACHE—prostate cancer	0.000254	0.0025	CbGpPWpGaD
Flumazenil—GABRA5—Transmission across Chemical Synapses—PRKACB—prostate cancer	0.000253	0.00249	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—NGFR—prostate cancer	0.000253	0.00249	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—PLCB2—prostate cancer	0.000251	0.00247	CbGpPWpGaD
Flumazenil—GABRG2—Transmission across Chemical Synapses—ACHE—prostate cancer	0.000249	0.00245	CbGpPWpGaD
Flumazenil—GABRA3—Transmission across Chemical Synapses—PRKACB—prostate cancer	0.000249	0.00245	CbGpPWpGaD
Flumazenil—Hypersensitivity—Epirubicin—prostate cancer	0.000247	0.000275	CcSEcCtD
Flumazenil—GABRA5—Orphan transporters—PPARA—prostate cancer	0.000247	0.00243	CbGpPWpGaD
Flumazenil—Urticaria—Doxorubicin—prostate cancer	0.000247	0.000275	CcSEcCtD
Flumazenil—GABRA3—Neuronal System—PLCB2—prostate cancer	0.000247	0.00243	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000245	0.00241	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—GNG5—prostate cancer	0.000245	0.00241	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—PRKACB—prostate cancer	0.000245	0.00241	CbGpPWpGaD
Flumazenil—GABRB3—Transmission across Chemical Synapses—PRKACB—prostate cancer	0.000243	0.00239	CbGpPWpGaD
Flumazenil—GABRA3—Orphan transporters—PPARA—prostate cancer	0.000242	0.00239	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—PLCB2—prostate cancer	0.000242	0.00238	CbGpPWpGaD
Flumazenil—Asthenia—Epirubicin—prostate cancer	0.000241	0.000268	CcSEcCtD
Flumazenil—GABRA3—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000241	0.00237	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—PLCB2—prostate cancer	0.000241	0.00237	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—SLC22A1—prostate cancer	0.000239	0.00236	CbGpPWpGaD
Flumazenil—GABRG2—Transmission across Chemical Synapses—PRKACB—prostate cancer	0.000239	0.00235	CbGpPWpGaD
Flumazenil—GABRA2—Orphan transporters—PPARA—prostate cancer	0.000238	0.00234	CbGpPWpGaD
Flumazenil—Pruritus—Epirubicin—prostate cancer	0.000238	0.000264	CcSEcCtD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—IL1RN—prostate cancer	0.000237	0.00233	CbGpPWpGaD
Flumazenil—GABRB3—Orphan transporters—PPARA—prostate cancer	0.000237	0.00233	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000237	0.00233	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—PLCB2—prostate cancer	0.000236	0.00233	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—SLC22A1—prostate cancer	0.000235	0.00231	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000235	0.00231	CbGpPWpGaD
Flumazenil—GABRG2—Orphan transporters—PPARA—prostate cancer	0.000232	0.00229	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—VAV3—prostate cancer	0.000232	0.00229	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—ACHE—prostate cancer	0.000231	0.00228	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—SLC22A1—prostate cancer	0.000231	0.00227	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000231	0.00227	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—SLC22A1—prostate cancer	0.00023	0.00226	CbGpPWpGaD
Flumazenil—Hypersensitivity—Doxorubicin—prostate cancer	0.000229	0.000255	CcSEcCtD
Flumazenil—GABRA4—Neuronal System—ACHE—prostate cancer	0.000229	0.00225	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—GNG5—prostate cancer	0.000228	0.00224	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000228	0.00224	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—SLC22A1—prostate cancer	0.000225	0.00222	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000225	0.00221	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—GNG5—prostate cancer	0.000224	0.0022	CbGpPWpGaD
Flumazenil—GABRA6—Orphan transporters—CREBBP—prostate cancer	0.000223	0.0022	CbGpPWpGaD
Flumazenil—Asthenia—Doxorubicin—prostate cancer	0.000223	0.000248	CcSEcCtD
Flumazenil—Dizziness—Epirubicin—prostate cancer	0.000222	0.000247	CcSEcCtD
Flumazenil—GABRA6—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000222	0.00218	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000222	0.00218	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—PRKACB—prostate cancer	0.000221	0.00218	CbGpPWpGaD
Flumazenil—GABRA4—Orphan transporters—CREBBP—prostate cancer	0.000221	0.00217	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—GNG5—prostate cancer	0.00022	0.00216	CbGpPWpGaD
Flumazenil—Pruritus—Doxorubicin—prostate cancer	0.00022	0.000245	CcSEcCtD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—ESR2—prostate cancer	0.000219	0.00216	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000219	0.00216	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000219	0.00216	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—PRKACB—prostate cancer	0.000219	0.00215	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—GNG5—prostate cancer	0.000218	0.00215	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—ACHE—prostate cancer	0.000218	0.00215	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—TH—prostate cancer	0.000218	0.00214	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—GNG5—prostate cancer	0.000214	0.00211	CbGpPWpGaD
Flumazenil—Vomiting—Epirubicin—prostate cancer	0.000213	0.000238	CcSEcCtD
Flumazenil—Rash—Epirubicin—prostate cancer	0.000212	0.000236	CcSEcCtD
Flumazenil—Dermatitis—Epirubicin—prostate cancer	0.000211	0.000235	CcSEcCtD
Flumazenil—GABRA6—Transmission across Chemical Synapses—COMT—prostate cancer	0.00021	0.00207	CbGpPWpGaD
Flumazenil—Headache—Epirubicin—prostate cancer	0.00021	0.000234	CcSEcCtD
Flumazenil—GABRA1—Transmission across Chemical Synapses—PRKACB—prostate cancer	0.000209	0.00205	CbGpPWpGaD
Flumazenil—GABRA4—Transmission across Chemical Synapses—COMT—prostate cancer	0.000208	0.00204	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—PLCB2—prostate cancer	0.000207	0.00203	CbGpPWpGaD
Flumazenil—Dizziness—Doxorubicin—prostate cancer	0.000205	0.000229	CcSEcCtD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—EGR1—prostate cancer	0.000205	0.00202	CbGpPWpGaD
Flumazenil—GABRA1—Orphan transporters—PPARA—prostate cancer	0.000203	0.002	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—ACHE—prostate cancer	0.000203	0.002	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000202	0.00198	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.0002	0.00197	CbGpPWpGaD
Flumazenil—Nausea—Epirubicin—prostate cancer	0.000199	0.000222	CcSEcCtD
Flumazenil—GABRA3—Neuronal System—ACHE—prostate cancer	0.000199	0.00196	CbGpPWpGaD
Flumazenil—Vomiting—Doxorubicin—prostate cancer	0.000198	0.00022	CcSEcCtD
Flumazenil—GABRA1—Neuronal System—SLC22A1—prostate cancer	0.000197	0.00194	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000196	0.00193	CbGpPWpGaD
Flumazenil—GABRA5—Orphan transporters—CREBBP—prostate cancer	0.000196	0.00193	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—ACHE—prostate cancer	0.000196	0.00193	CbGpPWpGaD
Flumazenil—Rash—Doxorubicin—prostate cancer	0.000196	0.000218	CcSEcCtD
Flumazenil—Dermatitis—Doxorubicin—prostate cancer	0.000196	0.000218	CcSEcCtD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—GJA1—prostate cancer	0.000195	0.00192	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000195	0.00192	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000195	0.00192	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—ACHE—prostate cancer	0.000195	0.00192	CbGpPWpGaD
Flumazenil—Headache—Doxorubicin—prostate cancer	0.000195	0.000217	CcSEcCtD
Flumazenil—GABRA5—Neuronal System—PRKACB—prostate cancer	0.000194	0.00191	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—AR—prostate cancer	0.000194	0.00191	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000193	0.0019	CbGpPWpGaD
Flumazenil—GABRA3—Orphan transporters—CREBBP—prostate cancer	0.000193	0.00189	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000192	0.00188	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000191	0.00188	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000191	0.00188	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—ACHE—prostate cancer	0.000191	0.00188	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—PRKACB—prostate cancer	0.000191	0.00188	CbGpPWpGaD
Flumazenil—GABRA2—Orphan transporters—CREBBP—prostate cancer	0.000189	0.00186	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000188	0.00185	CbGpPWpGaD
Flumazenil—GABRB3—Orphan transporters—CREBBP—prostate cancer	0.000188	0.00185	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000188	0.00185	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000188	0.00185	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—GNG5—prostate cancer	0.000187	0.00184	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—PRKACB—prostate cancer	0.000187	0.00184	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000187	0.00184	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000187	0.00184	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—PRKACB—prostate cancer	0.000186	0.00183	CbGpPWpGaD
Flumazenil—GABRG2—Orphan transporters—CREBBP—prostate cancer	0.000185	0.00182	CbGpPWpGaD
Flumazenil—GABRA5—Transmission across Chemical Synapses—COMT—prostate cancer	0.000185	0.00182	CbGpPWpGaD
Flumazenil—Nausea—Doxorubicin—prostate cancer	0.000185	0.000205	CcSEcCtD
Flumazenil—GABRG2—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000183	0.0018	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000183	0.0018	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—PRKACB—prostate cancer	0.000183	0.0018	CbGpPWpGaD
Flumazenil—GABRA3—Transmission across Chemical Synapses—COMT—prostate cancer	0.000181	0.00178	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.00018	0.00177	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—COMT—prostate cancer	0.000178	0.00175	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000178	0.00175	CbGpPWpGaD
Flumazenil—GABRB3—Transmission across Chemical Synapses—COMT—prostate cancer	0.000177	0.00174	CbGpPWpGaD
Flumazenil—GABRG2—Transmission across Chemical Synapses—COMT—prostate cancer	0.000174	0.00171	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—IL10—prostate cancer	0.000169	0.00167	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—ACHE—prostate cancer	0.000167	0.00164	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000166	0.00163	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000164	0.00162	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000164	0.00161	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—BAD—prostate cancer	0.000161	0.00159	CbGpPWpGaD
Flumazenil—GABRA1—Orphan transporters—CREBBP—prostate cancer	0.000161	0.00159	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—COMT—prostate cancer	0.000161	0.00159	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.00016	0.00158	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.00016	0.00158	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—PRKACB—prostate cancer	0.00016	0.00157	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—COMT—prostate cancer	0.000159	0.00157	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000158	0.00155	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—NR3C1—prostate cancer	0.000157	0.00154	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—APC—prostate cancer	0.000156	0.00154	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000155	0.00153	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—IRS1—prostate cancer	0.000154	0.00152	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000152	0.0015	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—COMT—prostate cancer	0.000152	0.00149	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000151	0.00149	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—GSK3B—prostate cancer	0.00015	0.00148	CbGpPWpGaD
Flumazenil—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.00015	0.00147	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000149	0.00146	CbGpPWpGaD
Flumazenil—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.000148	0.00145	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000147	0.00144	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000146	0.00143	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000145	0.00143	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000143	0.00141	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—HIF1A—prostate cancer	0.000143	0.00141	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—COMT—prostate cancer	0.000141	0.00139	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000141	0.00138	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.00014	0.00138	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—GNG5—prostate cancer	0.00014	0.00137	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—COMT—prostate cancer	0.000139	0.00137	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—MAP2K1—prostate cancer	0.000138	0.00136	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000138	0.00136	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000137	0.00135	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—COMT—prostate cancer	0.000136	0.00134	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—COMT—prostate cancer	0.000136	0.00133	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—COMT—prostate cancer	0.000133	0.00131	CbGpPWpGaD
Flumazenil—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.000131	0.00129	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.00013	0.00128	CbGpPWpGaD
Flumazenil—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.000129	0.00127	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000129	0.00127	CbGpPWpGaD
Flumazenil—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.000127	0.00125	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000126	0.00124	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—JAK2—prostate cancer	0.000126	0.00124	CbGpPWpGaD
Flumazenil—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.000126	0.00124	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000124	0.00122	CbGpPWpGaD
Flumazenil—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.000124	0.00122	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000123	0.00121	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000122	0.00121	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000121	0.00119	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—GNG5—prostate cancer	0.00012	0.00118	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.00012	0.00118	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000119	0.00117	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000118	0.00116	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000118	0.00116	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000117	0.00116	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—CREBBP—prostate cancer	0.000117	0.00115	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—COMT—prostate cancer	0.000116	0.00114	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000115	0.00113	CbGpPWpGaD
Flumazenil—GABRA6—Transmission across Chemical Synapses—MDM2—prostate cancer	0.000113	0.00111	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000112	0.0011	CbGpPWpGaD
Flumazenil—GABRA4—Transmission across Chemical Synapses—MDM2—prostate cancer	0.000111	0.00109	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000111	0.00109	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—CASP3—prostate cancer	0.00011	0.00108	CbGpPWpGaD
Flumazenil—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.000108	0.00106	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000107	0.00105	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—CTNNB1—prostate cancer	0.000106	0.00104	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000106	0.00104	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000106	0.00104	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000104	0.00103	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000103	0.00101	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000101	0.000992	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000101	0.000991	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.0001	0.000985	CbGpPWpGaD
Flumazenil—GABRA5—Transmission across Chemical Synapses—MDM2—prostate cancer	9.87e-05	0.000971	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—NCOA2—prostate cancer	9.85e-05	0.000969	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—PRKACB—prostate cancer	9.83e-05	0.000967	CbGpPWpGaD
Flumazenil—GABRA3—Transmission across Chemical Synapses—MDM2—prostate cancer	9.69e-05	0.000954	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—NCOA2—prostate cancer	9.67e-05	0.000951	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—SRC—prostate cancer	9.6e-05	0.000944	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—MDM2—prostate cancer	9.53e-05	0.000937	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—NCOA2—prostate cancer	9.5e-05	0.000935	CbGpPWpGaD
Flumazenil—GABRB3—Transmission across Chemical Synapses—MDM2—prostate cancer	9.46e-05	0.000931	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—NCOA1—prostate cancer	9.46e-05	0.000931	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—NCOA2—prostate cancer	9.44e-05	0.000929	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—SLC5A5—prostate cancer	9.39e-05	0.000924	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—NCOA1—prostate cancer	9.34e-05	0.000919	CbGpPWpGaD
Flumazenil—GABRG2—Transmission across Chemical Synapses—MDM2—prostate cancer	9.29e-05	0.000914	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—NCOA2—prostate cancer	9.27e-05	0.000912	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—CXCL8—prostate cancer	9.26e-05	0.000912	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—STAT3—prostate cancer	9.25e-05	0.000911	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—SLC5A5—prostate cancer	9.22e-05	0.000908	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	9.06e-05	0.000892	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—SLC5A5—prostate cancer	9.01e-05	0.000886	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—RXRA—prostate cancer	9e-05	0.000885	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—RXRA—prostate cancer	8.88e-05	0.000874	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—CASP3—prostate cancer	8.87e-05	0.000872	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	8.84e-05	0.00087	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—MDM2—prostate cancer	8.62e-05	0.000848	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—PRKACB—prostate cancer	8.59e-05	0.000845	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	8.55e-05	0.000841	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—MDM2—prostate cancer	8.51e-05	0.000837	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—NCOA1—prostate cancer	8.3e-05	0.000816	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—NCOA1—prostate cancer	8.15e-05	0.000802	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—MDM2—prostate cancer	8.12e-05	0.000799	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—NCOA2—prostate cancer	8.1e-05	0.000797	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—NCOA1—prostate cancer	8.01e-05	0.000788	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—NCOA1—prostate cancer	7.95e-05	0.000783	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—EP300—prostate cancer	7.94e-05	0.000782	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—RXRA—prostate cancer	7.89e-05	0.000777	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—NCOA1—prostate cancer	7.81e-05	0.000769	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—RXRA—prostate cancer	7.75e-05	0.000763	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	7.73e-05	0.000761	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—RXRA—prostate cancer	7.62e-05	0.000749	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—RXRA—prostate cancer	7.57e-05	0.000745	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—MDM2—prostate cancer	7.56e-05	0.000744	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—VEGFA—prostate cancer	7.52e-05	0.00074	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—RXRA—prostate cancer	7.43e-05	0.000731	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—MDM2—prostate cancer	7.43e-05	0.000731	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—MDM2—prostate cancer	7.3e-05	0.000718	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—MDM2—prostate cancer	7.25e-05	0.000713	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—MDM2—prostate cancer	7.12e-05	0.000701	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—PPARA—prostate cancer	6.87e-05	0.000676	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—NCOA1—prostate cancer	6.83e-05	0.000672	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—PPARA—prostate cancer	6.78e-05	0.000668	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—RXRA—prostate cancer	6.49e-05	0.000639	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—MDM2—prostate cancer	6.22e-05	0.000612	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—PPARA—prostate cancer	6.03e-05	0.000593	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—AKT1—prostate cancer	5.96e-05	0.000587	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—PPARA—prostate cancer	5.92e-05	0.000583	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—PPARA—prostate cancer	5.82e-05	0.000572	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—PPARA—prostate cancer	5.78e-05	0.000569	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—PPARA—prostate cancer	5.68e-05	0.000558	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—CREBBP—prostate cancer	5.46e-05	0.000537	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—CREBBP—prostate cancer	5.39e-05	0.00053	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—IL6—prostate cancer	5.2e-05	0.000512	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—PPARA—prostate cancer	4.96e-05	0.000488	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—CREBBP—prostate cancer	4.79e-05	0.000471	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—CREBBP—prostate cancer	4.7e-05	0.000463	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—CREBBP—prostate cancer	4.62e-05	0.000455	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—CREBBP—prostate cancer	4.59e-05	0.000452	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—CREBBP—prostate cancer	4.51e-05	0.000443	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.94e-05	0.000388	CbGpPWpGaD
